Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End Users (Hospital, Ambulatory surgical centers) - Global Forecast to 2027
The global bone growth stimulators market is valued at an estimated USD 1.8 billion by 2027 from an estimated USD 1.4 billion in 2022, at a CAGR of 5.9% from 2022 to 2027 during forecast period.The growing demand for bone growth stimulators in spinal fusion surgeries applications; the rising preference for non-surgical and non invasive treatment.
“The bone growth stimulators devices segment accounted for the highest growth rate in the bone growth stimulation devices market, by product, during the forecast period.”
Based on product, the global bone growth stimulation devices market is segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators and Implanted Bone Growth Stimulators. In 2021, the external Bone Growth Stimulators segment accounted for the largest share of the global bone growth stimulators market. This segment is also expected to grow at the highest rate during the forecast period. The largest share of this segment can be attributed to the advantages of external devices over internal/implanted devices, these are less expensive, noninvasive, and do not require surgeries for implantation and removal which will drive the market growth.
“Spinal fusion surgeries segment accounted for the highest CAGR”
On the basis of application, the global bone growth stimulators market is segmented into - spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. In 2021, the spinal fusion surgeries segment accounted for the largest share of the bone growth stimulators market. Factors supporting the growth increasing growing geriatric population and the rising number of spine procedures.
“The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.”
The bone growth stimulators market is segmented into - North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. The bone growth stimulators market in several Asia-Pacific countries is expected to witness high growth during the forecast period owing to the aging population, rapid economic growth in emerging APAC countries and rising volume of spine procedures.
A breakdown of the primary participants referred to for this report is provided below:
This report studies the bone growth stimulators market based on the product, application, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall bone growth stimulators market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.
“The bone growth stimulators devices segment accounted for the highest growth rate in the bone growth stimulation devices market, by product, during the forecast period.”
Based on product, the global bone growth stimulation devices market is segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators and Implanted Bone Growth Stimulators. In 2021, the external Bone Growth Stimulators segment accounted for the largest share of the global bone growth stimulators market. This segment is also expected to grow at the highest rate during the forecast period. The largest share of this segment can be attributed to the advantages of external devices over internal/implanted devices, these are less expensive, noninvasive, and do not require surgeries for implantation and removal which will drive the market growth.
“Spinal fusion surgeries segment accounted for the highest CAGR”
On the basis of application, the global bone growth stimulators market is segmented into - spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. In 2021, the spinal fusion surgeries segment accounted for the largest share of the bone growth stimulators market. Factors supporting the growth increasing growing geriatric population and the rising number of spine procedures.
“The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period.”
The bone growth stimulators market is segmented into - North America, Europe, the Asia Pacific, Latin America, and Middle East and Africa. The bone growth stimulators market in several Asia-Pacific countries is expected to witness high growth during the forecast period owing to the aging population, rapid economic growth in emerging APAC countries and rising volume of spine procedures.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: Director-level–14%, C-level–10%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, and the Middle East & Africa–3%
- Orthofix Medical Inc. (US)
- Enovis Coperation (US)
- ZimVie (US)
- Bioventus LLC (US)
- Medtronic plc (Ireland)
- Stryker (US)
- DePuy Synthes (US)
- Arthrex, Inc. (US)
- Isto Biologics (US)
- Terumo Corporation (Japan)
- Ember Therapeutics, Inc. (US)
- Ossatec Benelux Ltd. (Netherlands)
- Altis Biologics (Pty) Ltd. (South Africa)
- Regen Lab SA (Switzerland),
- ITO Co., Ltd. (Japan)
- Elizur Corporation (US)
- BTT Health GmbH (Germany)
- Stimulate Health (Canada)
- VQ OrthoCare (US)
- Kinex Medical Company, LLC (US)
This report studies the bone growth stimulators market based on the product, application, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall bone growth stimulators market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
FIGURE 9 ASSUMPTIONS FOR STUDY
TABLE 1 INDICATORS AND ASSUMPTIONS
2.5 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BONE GROWTH STIMULATORS MARKET
4 PREMIUM INSIGHTS
4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW
FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET
4.2 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 15 BONE GROWTH STIMULATION DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4.3 GEOGRAPHIC SNAPSHOT OF BONE GROWTH STIMULATORS MARKET
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 BONE GROWTH STIMULATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments
5.2.1.2 Increasing target patient population
5.2.1.3 Rising number of sports and accident-related orthopedic injuries
FIGURE 18 US: INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES (2021)
5.2.1.4 Rising geriatric population
TABLE 2 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050
5.2.2 MARKET RESTRAINTS
5.2.2.1 Limited medical reimbursement for bone stimulation products
5.2.2.2 High treatment costs associated with BMP and PRP products
5.2.2.3 Limited clinical evidence to support therapeutic efficacy of bone growth stimulators
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Increasing use of PRP in other applications
5.2.3.3 Rising number of hospitals and surgical centers
TABLE 3 NUMBER OF ASCS AND OPERATING ROOMS, 2015–2020
5.2.4 MARKET CHALLENGES
5.2.4.1 Lack of access to diagnostics
5.2.4.2 Side effects associated with BMP-based orthopedic treatment
TABLE 4 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2
TABLE 5 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO)
5.3 PRICING ANALYSIS
TABLE 6 PRICE RANGE FOR BONE GROWTH STIMULATORS
5.4 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
FIGURE 20 BONE GROWTH STIMULATORS: SUPPLY CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 OVERVIEW
TABLE 7 BONE GROWTH STIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.2 THREAT OF NEW ENTRANTS
5.6.3 THREAT OF SUBSTITUTES
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 BARGAINING POWER OF BUYERS
5.6.6 DEGREE OF COMPETITION
5.7 ECOSYSTEM ANALYSIS
TABLE 8 BONE GROWTH STIMULATORS: ROLE IN ECOSYSTEM
FIGURE 21 KEY PLAYERS IN BONE GROWTH STIMULATORS ECOSYSTEM
5.8 REGULATORY ANALYSIS
5.8.1 NORTH AMERICA
5.8.1.1 US
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.1.2 Canada
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.2 EUROPE
5.8.3 ASIA PACIFIC
5.8.3.1 Japan
TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.8.3.2 China
TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.8.3.3 India
5.9 PATENT ANALYSIS
5.9.1 PATENT TRENDS FOR BONE GROWTH STIMULATORS
FIGURE 22 PATENT ANALYSIS (JANUARY 2013–SEPTEMBER 2022)
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 23 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BONE GROWTH STIMULATOR PATENTS, JANUARY 2013–SEPTEMBER 2022
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR BONE GROWTH STIMULATOR MANUFACTURERS
FIGURE 24 REVENUE SHIFT FOR BONE GROWTH STIMULATORS
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 14 BONE GROWTH STIMULATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12 TECHNOLOGY ANALYSIS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
5.14 TRADE ANALYSIS
5.14.1 TRADE ANALYSIS FOR BONE GROWTH STIMULATORS
TABLE 17 IMPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 18 EXPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017–2021 (USD MILLION)
6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 19 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 BONE GROWTH STIMULATION DEVICES
TABLE 20 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1 EXTERNAL BONE GROWTH STIMULATORS
TABLE 22 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.1 Pulsed electromagnetic field devices
6.2.1.1.1 Pulsed electromagnetic field devices to witness highest growth in external bone growth stimulators market
TABLE 24 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.2 Combined magnetic field devices
6.2.1.2.1 Combined magnetic field devices portable, battery-powered, and noninvasive
TABLE 25 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.3 Capacitive coupling devices
6.2.1.3.1 Need for frequent battery replacement or recharge—disadvantage associated with CC devices
TABLE 26 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 ULTRASONIC BONE GROWTH STIMULATORS
6.2.2.1 Used in treatment of nonunion bone fractures and failed arthrodesis
TABLE 27 HCPCS CODE
TABLE 28 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.3 IMPLANTED BONE GROWTH STIMULATORS
6.2.3.1 Implanted bone growth stimulators provide constant stimulation of bone directly at fracture site
TABLE 29 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 BONE MORPHOGENETIC PROTEINS
6.3.1 SAFE AND EFFECTIVE ALTERNATIVES TO BONE GRAFTS
TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 PLATELET-RICH PLASMA
6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET
TABLE 31 PLATELET-RICH PLASMA MARKET, BY REGION, 2020–2027 (USD MILLION)
7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 32 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 SPINAL FUSION SURGERIES
7.2.1 SPINAL FUSION SURGERIES TO DOMINATE BONE GROWTH STIMULATORS MARKET
TABLE 33 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2027 (USD MILLION)
7.3 DELAYED UNION AND NONUNION BONE FRACTURES
7.3.1 INCREASING NUMBER OF DELAYED UNION AND NONUNION BONE FRACTURES TO INCREASE DEMAND FOR BONE GROWTH STIMULATORS
TABLE 34 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION AND NONUNION BONE FRACTURES, BY REGION, 2020–2027 (USD MILLION)
7.4 ORAL AND MAXILLOFACIAL SURGERIES
7.4.1 BMPS USED IN ORAL AND MAXILLOFACIAL SURGERIES TO FORM BASE FOR DENTAL IMPLANTS
TABLE 35 BONE GROWTH STIMULATORS MARKET FOR ORAL AND MAXILLOFACIAL SURGERIES, BY REGION, 2020–2027 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 36 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 BONE GROWTH STIMULATORS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 37 BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
8.2.1 LARGEST AND FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS
TABLE 38 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS AND ASCS, BY REGION, 2020–2027 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
TABLE 39 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO DRIVE MARKET
TABLE 40 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
9 BONE GROWTH STIMULATORS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 41 BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 High burden of sports-related injuries to drive market
TABLE 48 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 49 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 52 US: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Market growth driven by rising incidence of bone-related diseases
TABLE 53 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 54 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 57 CANADA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Largest market for bone growth stimulators in Europe
FIGURE 28 GERMANY: POPULATION AGED 65 AND ABOVE, 2015–2021 (MILLION)
TABLE 64 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing funding by public and private organizations to drive market
TABLE 69 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 UK: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 UK: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising prevalence of diabetes to support market growth
TABLE 74 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market
TABLE 79 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 80 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 ITALY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 83 ITALY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
TABLE 84 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 85 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 SPAIN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 88 SPAIN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 89 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 90 REST OF EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 REST OF EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 93 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 94 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 95 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 96 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan dominates Asia Pacific bone growth stimulators market
TABLE 100 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 JAPAN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 JAPAN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive market
TABLE 105 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 CHINA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 109 CHINA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing number of orthopedic surgeries to support market growth
TABLE 110 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 111 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 INDIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 INDIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Availability of grants for development of advanced treatments to support market growth
TABLE 115 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives positively impact market growth
TABLE 120 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 124 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 125 GERIATRIC POPULATION, BY COUNTRY, 2015–2021
TABLE 126 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 REST OF ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 REST OF ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 130 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 131 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 132 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 133 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 136 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Modernization of healthcare facilities to drive market
TABLE 137 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 138 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 141 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market
TABLE 142 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 143 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 MEXICO: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 146 MEXICO: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 147 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 REST OF LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 REST OF LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF BONE GROWTH STIMULATORS
TABLE 152 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 156 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
TABLE 157 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BONE GROWTH STIMULATORS MARKET
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
10.4 MARKET SHARE ANALYSIS
TABLE 158 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PARTICIPANTS
10.5.4 PERVASIVE PLAYERS
FIGURE 31 BONE GROWTH STIMULATORS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021
10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
10.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
TABLE 159 PRODUCT FOOTPRINT OF COMPANIES
TABLE 160 REGIONAL FOOTPRINT OF COMPANIES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 161 KEY PRODUCT LAUNCHES, JANUARY 2019–AUGUST 2022
10.8.2 DEALS
TABLE 162 KEY DEALS, JANUARY 2019–AUGUST 2022
10.8.3 OTHER DEVELOPMENTS
TABLE 163 OTHER KEY DEVELOPMENTS, JANUARY 2019–AUGUST 2022
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 ORTHOFIX MEDICAL INC.
TABLE 164 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW
FIGURE 33 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2021)
11.1.2 DEPUY SYNTHES
TABLE 165 DEPUY SYNTHES: BUSINESS OVERVIEW
FIGURE 34 DEPUY SYNTHES: COMPANY SNAPSHOT (2021)
11.1.3 STRYKER
TABLE 166 STRYKER: BUSINESS OVERVIEW
FIGURE 35 STRYKER: COMPANY SNAPSHOT (2021)
11.1.4 BIOVENTUS LLC
TABLE 167 BIOVENTUS LLC: BUSINESS OVERVIEW
FIGURE 36 BIOVENTUS LLC: COMPANY SNAPSHOT (2021)
11.1.5 MEDTRONIC PLC
TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.6 ENOVIS CORPORATION (FORMERLY COLFAX)
TABLE 169 ENOVIS CORPORATION (FORMERLY COLFAX): BUSINESS OVERVIEW
FIGURE 38 ENOVIS CORPORATION: COMPANY SNAPSHOT (2021)
11.1.7 ZIMVIE INC. (SUBSIDIARY OF ZIMMER BIOMET)
TABLE 170 ZIMVIE INC.: BUSINESS OVERVIEW
FIGURE 39 ZIMVIE INC.: COMPANY SNAPSHOT (2021)
11.1.8 ARTHREX, INC.
TABLE 171 ARTHREX, INC.: BUSINESS OVERVIEW
11.1.9 TERUMO CORPORATION
TABLE 172 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
11.1.10 OSSATEC BENELUX LTD.
TABLE 173 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW
11.1.11 ISTO BIOLOGICS
TABLE 174 ISTO BIOLOGICS: BUSINESS OVERVIEW
11.1.12 EMBER THERAPEUTICS, INC.
TABLE 175 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW
11.1.13 REGEN LAB SA
TABLE 176 REGEN LAB SA: BUSINESS OVERVIEW
11.1.14 ALTIS BIOLOGICS (PTY) LTD.
TABLE 177 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW
11.1.15 ITO CO., LTD.
TABLE 178 ITO CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER COMPANIES
11.2.1 ELIZUR CORPORATION
11.2.2 BTT HEALTH GMBH
11.2.3 STIMULATE HEALTH
11.2.4 VQ ORTHOCARE
11.2.5 KINEX MEDICAL COMPANY, LLC
*Details on Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1 GROWTH FORECAST
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 7 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
FIGURE 9 ASSUMPTIONS FOR STUDY
TABLE 1 INDICATORS AND ASSUMPTIONS
2.5 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BONE GROWTH STIMULATORS MARKET
4 PREMIUM INSIGHTS
4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW
FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET
4.2 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT AND COUNTRY (2022)
FIGURE 15 BONE GROWTH STIMULATION DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
4.3 GEOGRAPHIC SNAPSHOT OF BONE GROWTH STIMULATORS MARKET
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 BONE GROWTH STIMULATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments
5.2.1.2 Increasing target patient population
5.2.1.3 Rising number of sports and accident-related orthopedic injuries
FIGURE 18 US: INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES (2021)
5.2.1.4 Rising geriatric population
TABLE 2 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050
5.2.2 MARKET RESTRAINTS
5.2.2.1 Limited medical reimbursement for bone stimulation products
5.2.2.2 High treatment costs associated with BMP and PRP products
5.2.2.3 Limited clinical evidence to support therapeutic efficacy of bone growth stimulators
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Increasing use of PRP in other applications
5.2.3.3 Rising number of hospitals and surgical centers
TABLE 3 NUMBER OF ASCS AND OPERATING ROOMS, 2015–2020
5.2.4 MARKET CHALLENGES
5.2.4.1 Lack of access to diagnostics
5.2.4.2 Side effects associated with BMP-based orthopedic treatment
TABLE 4 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2
TABLE 5 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO)
5.3 PRICING ANALYSIS
TABLE 6 PRICE RANGE FOR BONE GROWTH STIMULATORS
5.4 VALUE CHAIN ANALYSIS
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.5 SUPPLY CHAIN ANALYSIS
5.5.1 PROMINENT COMPANIES
5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.5.3 END USERS
FIGURE 20 BONE GROWTH STIMULATORS: SUPPLY CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
5.6.1 OVERVIEW
TABLE 7 BONE GROWTH STIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.6.2 THREAT OF NEW ENTRANTS
5.6.3 THREAT OF SUBSTITUTES
5.6.4 BARGAINING POWER OF SUPPLIERS
5.6.5 BARGAINING POWER OF BUYERS
5.6.6 DEGREE OF COMPETITION
5.7 ECOSYSTEM ANALYSIS
TABLE 8 BONE GROWTH STIMULATORS: ROLE IN ECOSYSTEM
FIGURE 21 KEY PLAYERS IN BONE GROWTH STIMULATORS ECOSYSTEM
5.8 REGULATORY ANALYSIS
5.8.1 NORTH AMERICA
5.8.1.1 US
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.1.2 Canada
TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.8.2 EUROPE
5.8.3 ASIA PACIFIC
5.8.3.1 Japan
TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.8.3.2 China
TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.8.3.3 India
5.9 PATENT ANALYSIS
5.9.1 PATENT TRENDS FOR BONE GROWTH STIMULATORS
FIGURE 22 PATENT ANALYSIS (JANUARY 2013–SEPTEMBER 2022)
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 23 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BONE GROWTH STIMULATOR PATENTS, JANUARY 2013–SEPTEMBER 2022
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR BONE GROWTH STIMULATOR MANUFACTURERS
FIGURE 24 REVENUE SHIFT FOR BONE GROWTH STIMULATORS
5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
TABLE 14 BONE GROWTH STIMULATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.12 TECHNOLOGY ANALYSIS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS (%)
5.13.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
TABLE 16 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
5.14 TRADE ANALYSIS
5.14.1 TRADE ANALYSIS FOR BONE GROWTH STIMULATORS
TABLE 17 IMPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 18 EXPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY, 2017–2021 (USD MILLION)
6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 19 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 BONE GROWTH STIMULATION DEVICES
TABLE 20 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1 EXTERNAL BONE GROWTH STIMULATORS
TABLE 22 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.1 Pulsed electromagnetic field devices
6.2.1.1.1 Pulsed electromagnetic field devices to witness highest growth in external bone growth stimulators market
TABLE 24 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.2 Combined magnetic field devices
6.2.1.2.1 Combined magnetic field devices portable, battery-powered, and noninvasive
TABLE 25 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1.3 Capacitive coupling devices
6.2.1.3.1 Need for frequent battery replacement or recharge—disadvantage associated with CC devices
TABLE 26 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 ULTRASONIC BONE GROWTH STIMULATORS
6.2.2.1 Used in treatment of nonunion bone fractures and failed arthrodesis
TABLE 27 HCPCS CODE
TABLE 28 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.3 IMPLANTED BONE GROWTH STIMULATORS
6.2.3.1 Implanted bone growth stimulators provide constant stimulation of bone directly at fracture site
TABLE 29 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 BONE MORPHOGENETIC PROTEINS
6.3.1 SAFE AND EFFECTIVE ALTERNATIVES TO BONE GRAFTS
TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 PLATELET-RICH PLASMA
6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET
TABLE 31 PLATELET-RICH PLASMA MARKET, BY REGION, 2020–2027 (USD MILLION)
7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 32 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 SPINAL FUSION SURGERIES
7.2.1 SPINAL FUSION SURGERIES TO DOMINATE BONE GROWTH STIMULATORS MARKET
TABLE 33 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2027 (USD MILLION)
7.3 DELAYED UNION AND NONUNION BONE FRACTURES
7.3.1 INCREASING NUMBER OF DELAYED UNION AND NONUNION BONE FRACTURES TO INCREASE DEMAND FOR BONE GROWTH STIMULATORS
TABLE 34 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION AND NONUNION BONE FRACTURES, BY REGION, 2020–2027 (USD MILLION)
7.4 ORAL AND MAXILLOFACIAL SURGERIES
7.4.1 BMPS USED IN ORAL AND MAXILLOFACIAL SURGERIES TO FORM BASE FOR DENTAL IMPLANTS
TABLE 35 BONE GROWTH STIMULATORS MARKET FOR ORAL AND MAXILLOFACIAL SURGERIES, BY REGION, 2020–2027 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 36 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 BONE GROWTH STIMULATORS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 37 BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
8.2.1 LARGEST AND FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS
TABLE 38 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS AND ASCS, BY REGION, 2020–2027 (USD MILLION)
8.3 HOME CARE SETTINGS
8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
TABLE 39 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)
8.4 ACADEMIC AND RESEARCH INSTITUTES
8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO DRIVE MARKET
TABLE 40 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
9 BONE GROWTH STIMULATORS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 41 BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 42 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 High burden of sports-related injuries to drive market
TABLE 48 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 49 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 52 US: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Market growth driven by rising incidence of bone-related diseases
TABLE 53 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 54 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 57 CANADA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Largest market for bone growth stimulators in Europe
FIGURE 28 GERMANY: POPULATION AGED 65 AND ABOVE, 2015–2021 (MILLION)
TABLE 64 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 GERMANY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Increasing funding by public and private organizations to drive market
TABLE 69 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 UK: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 73 UK: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising prevalence of diabetes to support market growth
TABLE 74 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 75 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 78 FRANCE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market
TABLE 79 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 80 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 ITALY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 83 ITALY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
TABLE 84 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 85 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 SPAIN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 88 SPAIN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 89 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 90 REST OF EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 REST OF EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 93 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 29 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT
TABLE 94 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 95 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 96 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan dominates Asia Pacific bone growth stimulators market
TABLE 100 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 JAPAN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 JAPAN: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive market
TABLE 105 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 CHINA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 109 CHINA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing number of orthopedic surgeries to support market growth
TABLE 110 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 111 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 112 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 INDIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 INDIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Availability of grants for development of advanced treatments to support market growth
TABLE 115 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Supportive government initiatives positively impact market growth
TABLE 120 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 124 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC
TABLE 125 GERIATRIC POPULATION, BY COUNTRY, 2015–2021
TABLE 126 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 REST OF ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 REST OF ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 130 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 131 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 132 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 133 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 135 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 136 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Modernization of healthcare facilities to drive market
TABLE 137 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 138 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 141 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market
TABLE 142 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 143 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 MEXICO: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 146 MEXICO: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 147 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 REST OF LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 REST OF LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF BONE GROWTH STIMULATORS
TABLE 152 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 156 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
TABLE 157 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BONE GROWTH STIMULATORS MARKET
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
10.4 MARKET SHARE ANALYSIS
TABLE 158 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PARTICIPANTS
10.5.4 PERVASIVE PLAYERS
FIGURE 31 BONE GROWTH STIMULATORS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021
10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
10.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
TABLE 159 PRODUCT FOOTPRINT OF COMPANIES
TABLE 160 REGIONAL FOOTPRINT OF COMPANIES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 161 KEY PRODUCT LAUNCHES, JANUARY 2019–AUGUST 2022
10.8.2 DEALS
TABLE 162 KEY DEALS, JANUARY 2019–AUGUST 2022
10.8.3 OTHER DEVELOPMENTS
TABLE 163 OTHER KEY DEVELOPMENTS, JANUARY 2019–AUGUST 2022
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
11.1.1 ORTHOFIX MEDICAL INC.
TABLE 164 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW
FIGURE 33 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2021)
11.1.2 DEPUY SYNTHES
TABLE 165 DEPUY SYNTHES: BUSINESS OVERVIEW
FIGURE 34 DEPUY SYNTHES: COMPANY SNAPSHOT (2021)
11.1.3 STRYKER
TABLE 166 STRYKER: BUSINESS OVERVIEW
FIGURE 35 STRYKER: COMPANY SNAPSHOT (2021)
11.1.4 BIOVENTUS LLC
TABLE 167 BIOVENTUS LLC: BUSINESS OVERVIEW
FIGURE 36 BIOVENTUS LLC: COMPANY SNAPSHOT (2021)
11.1.5 MEDTRONIC PLC
TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.6 ENOVIS CORPORATION (FORMERLY COLFAX)
TABLE 169 ENOVIS CORPORATION (FORMERLY COLFAX): BUSINESS OVERVIEW
FIGURE 38 ENOVIS CORPORATION: COMPANY SNAPSHOT (2021)
11.1.7 ZIMVIE INC. (SUBSIDIARY OF ZIMMER BIOMET)
TABLE 170 ZIMVIE INC.: BUSINESS OVERVIEW
FIGURE 39 ZIMVIE INC.: COMPANY SNAPSHOT (2021)
11.1.8 ARTHREX, INC.
TABLE 171 ARTHREX, INC.: BUSINESS OVERVIEW
11.1.9 TERUMO CORPORATION
TABLE 172 TERUMO CORPORATION: BUSINESS OVERVIEW
FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
11.1.10 OSSATEC BENELUX LTD.
TABLE 173 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW
11.1.11 ISTO BIOLOGICS
TABLE 174 ISTO BIOLOGICS: BUSINESS OVERVIEW
11.1.12 EMBER THERAPEUTICS, INC.
TABLE 175 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW
11.1.13 REGEN LAB SA
TABLE 176 REGEN LAB SA: BUSINESS OVERVIEW
11.1.14 ALTIS BIOLOGICS (PTY) LTD.
TABLE 177 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW
11.1.15 ITO CO., LTD.
TABLE 178 ITO CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER COMPANIES
11.2.1 ELIZUR CORPORATION
11.2.2 BTT HEALTH GMBH
11.2.3 STIMULATE HEALTH
11.2.4 VQ ORTHOCARE
11.2.5 KINEX MEDICAL COMPANY, LLC
*Details on Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
